UNIVERSITY OF CALIFORNIA, SAN DIEGO
Using miRNA to identify new therapeutic pathways for dilated cardiomyopathy
Using miRNA to identify new therapeutic pathways for dilated cardiomyopathy is a funding opportunity from UNIVERSITY OF CALIFORNIA, SAN DIEGO, up to 248743, closing July 31, 2027.
Jul 31, 2027
(365d left)Overview
SUMMARY Dilated cardiomyopathy (DCM) associated heart failure is a leading cause of death and new therapeutic strategies are needed. Pathogenic variants in over 50 genes contribute to DCM, but the molecular mechanisms of disease are poorly understood. Much remains to be done to understand disease mechanisms and…